Article and Video CATEGORIES
Dr. Ravi Salgia, University of Chicago, provides his perspective on the likelihood that molecular oncology principles and targeted therapies will become more broadly applicable for patients with squamous and other lung cancer subtypes.
[powerpress]
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Forum Discussions
Hi Revtoby, Welcome to Grace. I'm sorry you and your wife are worried about cancer but we couldn't say whether or not your wife's leison is cancer no matter how much...
Canyil, I'm sorry your father and you are going through this. While we can't give urgent help we are her to help offer info and resources to help make the best...
Hello and welcome to Grace. I'm sorry you're going through this worry. It is normal to watch a small very slow-growing solid nodule with once-a-year CT scans. Anything less than a...
Thanks you very much. So in summary the course of action taken suggested by lung specalist (re scan in 12 months) seems appropriate? And a PET at this stage is probably...
I can't say what is appropriate for you that's only something your professionals with all your information can do. However, when someone has a solid nodule less than a cm that...